 |
|
Physostigmine in Mania
Kenneth L. Davis, MD;
Philip A. Berger, MD;
Leo E. Hollister, MD;
Emanuel Defraites, MD
Arch Gen Psychiatry. 1978;35(1):119-122.
Abstract
• Seven men and one woman with primary affective disorder, mania, were given a slow intravenous infusion of physostigmine salicylate. In six patients, mood and thought content changed from mania toward depression as evaluated by either a visual analog mood scale or the Pettersen scale. Two other patients, who were the only predominantly irritable manics in the study, demonstrated little change in their hostility, although one became somewhat depressed. These findings are consistent with earlier reports of suppression of manic symptoms after physostigmine infusion in some but not all patients with mania. The pharmacologic mechanism of physostigmine reversal of manic symptoms may be the direct result of increased cholinergic activity or a result of the effect of increased cholinergic activity on other brain neurotransmitters.
Author Affiliations
From the Psychiatric Clinical Research Center (Drs Davis, Berger, and Hollister), Veterans Administration Hospital, Palo Alto, Calif; the Stanford (Calif) University School of Medicine (Drs Davis, Berger, and Hollister); and the National Institute of Mental Health, Bethesda, Md (Dr Defraites).
Footnotes
Accepted for publication July 25, 1977.
Reprint requests to Veterans Administration Hospital, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Davis).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey and Drevets
Arch Gen Psychiatry 2006;63:1121-1129.
ABSTRACT
| FULL TEXT
Faster cholinergic REM sleep induction in euthymic patients with primary affective illness
Sitaram et al.
Science 1980;208:200-202.
ABSTRACT
Cholinomimetics and Memory: The Effect of Choline Chloride
Davis et al.
Arch Neurol 1980;37:49-52.
ABSTRACT
|
